Useful predictors of progression‐free survival for Japanese patients with LATITUDE‐high‐risk metastatic castration‐sensitive prostate cancer who received upfront abiraterone acetate

OBJECTIVE: Recently, hormonal therapy using abiraterone acetate, a second‐generation androgen receptor axis‐targeted agent, was reported to improve overall survival and progression‐free survival in men with LATITUDE‐high‐risk metastatic castration‐sensitive prostate cancer. This observational multic...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahara, Kiyoshi, Naiki, Taku, Ito, Toshiki, Nakane, Keita, Koie, Takuya, Yasui, Takahiro, Miyake, Hideaki, Shiroki, Ryoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles: Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299872/
https://www.ncbi.nlm.nih.gov/pubmed/34863085
http://dx.doi.org/10.1111/iju.14754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299872/
https://www.ncbi.nlm.nih.gov/pubmed/34863085
http://dx.doi.org/10.1111/iju.14754

Ejemplares similares